Daily Vaginal Application of Dienogest (Visanne©) for 3 Months in Symptomatic Deeply Infiltrating Rectovaginal Endometriosis: A Possible New Treatment Approach?

A 27-year-old patient suffering from deeply infiltrating rectovaginal endometriosis was treated with 2 mg/day dienogest vaginally for 3 months. The therapy was tolerated very well. The patient reported less side effects compared to the oral use of dienogest. After 3 months of dienogest treatment, th...

Descripción completa

Detalles Bibliográficos
Autor principal: Ebert, Andreas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971254/
https://www.ncbi.nlm.nih.gov/pubmed/29862105
http://dx.doi.org/10.1155/2018/8175870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971254/
https://www.ncbi.nlm.nih.gov/pubmed/29862105
http://dx.doi.org/10.1155/2018/8175870

Ejemplares similares